Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Dna Group (T.R.) Ltd specializes in biotechnology with a focus on genetic testing and personalized medicine. Its competitive position is bolstered by proprietary technology in DNA sequencing and analysis, primarily serving the Israeli market and expanding into Europe. The company's unique selling proposition lies in its 100% gross margin, indicating a highly efficient operational model.
Dna Group generates revenue through its advanced genetic testing services, leveraging proprietary technology that allows for high accuracy and rapid turnaround times. The company benefits from strong pricing power due to its unique offerings and the increasing demand for personalized medicine.
Regulatory approvals for new genetic tests
Expansion into new markets, particularly in Europe
Partnerships with healthcare providers
Advancements in genetic research and technology
Regulatory changes impacting genetic testing standards
Technological disruption from emerging competitors
Increased competition from established biotech firms
Potential for new entrants leveraging advanced technology
High debt levels relative to equity may pose liquidity risks
Negative ROE indicates potential inefficiencies in capital utilization
low - The demand for genetic testing is relatively inelastic and not closely tied to economic cycles.
Minimal impact as the company does not rely heavily on debt financing; however, higher rates could affect investment in R&D.
minimal - The company has a high debt-to-equity ratio but operates with a cash flow profile that mitigates credit risk.
growth - Investors are likely attracted to the potential for rapid revenue growth driven by innovation in genetic testing.
high - Given the company's small market cap and high operational leverage, the stock may exhibit significant price volatility.
